‌

US Patent 11939323 Methods of making a modulator of hemoglobin

Patent 11939323 was granted and assigned to Global Blood Therapeutics on March, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Patent Applicant

Global Blood Therapeutics

Current Assignee

Global Blood Therapeutics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

119393230

Patent Inventor Names

Devon Mundal0

Todd Daniel Nelson0

Ana Cristina Parra Rivera0

Benjamin Graetz0

Morin M. Frick0

Shinji Fujimori0

Xiang Wang0

Date of Patent

March 26, 2024

Patent Application Number

177445250

Date Filed

May 13, 2022

Patent Citations

‌

US Patent 11548880 Modulators of hemoglobin

‌

US Patent 10683285 Modulators of hemoglobin

Patent Primary Examiner

CPC Code

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11939323 Methods of making a modulator of hemoglobin

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API